When people talk to me about healthcare in the U.S., it’s usually a conversation filled with frustration. Costs are out of control, inequities are real, and outcomes are often better in other developed nations. But as Dr. Carroll suggested, when we do a deep dive, we find incredible accomplishments that deserve attention, too. The challenge we face as a nation and the opportunities presented by that challenge lie in keeping what works and fixing what doesn’t.
For example, over the last half-century, vaccines and better treatments have helped drive childhood mortality rates down by more than 75%. Diseases like polio and smallpox are gone, and before the Hib vaccine, meningitis, epiglottitis, pneumonia, and sepsis were killing and disabling hundreds of kids every year.
Leukemia, a near-certain death sentence for a child, can now be treated with real hope. Despite this progress, we still trail behind many countries in infant and child mortality. Black infants die at twice the rate of white infants. What’s missing? Equal access to care and the social support for healthy beginnings.
The United States’ research is the envy of the world. The NIH spends more on medical science than any other nation, and its discoveries have represented the future of medicine. HIV is a manageable condition. We can cure Hepatitis C. So, what is the problem? A hepatitis C cure costs tens of thousands of dollars. Taxpayers fund the science, but patients can’t afford the drugs. If we used government purchasing power to lower costs, the drugs could reach more people.
How about regulation? The Food and Drug Administration reviews and approves new medicines faster than several of its peers. Cancer drugs often become available here months or years before they do in Europe. Unfortunately, some drugs end up offering slim benefits at exorbitant costs. It would be great to have quick access with stronger evidence at a fair price, but can we ever have quick, good, and cheap? It’s like the iron triangle of challenge.
How about medical education? The U.S. dominates the world with many of the best medical schools that draw students from across the globe. But we still don’t train enough doctors, especially in primary care and rural areas. We end up relying on immigrant physicians. High tuition costs are a major problem. If we expanded medical school slots, reduced debt burdens, and provided stronger incentives for service in underserved areas, we could match our educational excellence with workforce adequacy. Hence the pending IUP College of Osteopathic Medicine journey.
Recent safety and prevention initiatives have saved tens of thousands of lives and billions of dollars. But preventable errors still are one of the leading causes of death in this country. More coordination, transparency, and accountability could help to improve our healthcare institutions.
Since the introduction of the Affordable Care Act, millions of Americans have gained access to screenings like mammograms and colonoscopies. Early detection can make an enormous difference. But the recent Medicaid cuts will mean that millions will be uninsured or underinsured. By making prevention and wellness the key to healthcare, expanding coverage, and making healthcare affordable, prevention can become a reality rather than a privilege.
Dr. Carroll is right to celebrate the good news. But we can’t ignore that, despite spending nearly 17 percent of GDP on healthcare, Americans live shorter, less healthy lives than people in other successful nations. We’re not missing the science. We are missing the policy.
The answer? Expand coverage, enforce fair drug pricing, provide equity, train more physicians, and hold institutions accountable for safety. Then we have a system that is both world-class and fair. But that would mean deciding between social capitalism and savage capitalism. That’s the real challenge.
? This column draws on Aaron E. Carroll’s essay, “The Bright Spots of American Healthcare: A Beacon of Innovation and Progress,” published in The New York Times on September 5, 2025.